FDA can find no objections in CI audit. (Clinical investigators).(Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio; clinical investigator, ... article from: Bioresearch Monitoring Alert

This digital document is an article from Bioresearch Monitoring Alert, published by Washington Information Source on May 1, 2003. The length of the article is 7907 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.

Citation Details
Title: FDA can find no objections in CI audit. (Clinical investigators).(Metabolic and Atherosclerosis Research Center, Cincinnati, Ohio; clinical investigator, US Food and Drug Administration)
Author: Tamra Sami
Publication:Bioresearch Monitoring Alert (Newsletter)
Date: May 1, 2003
Publisher: Washington Information Source
Volume: 3 Issue: 5 Page: 11

Distributed by Thomson Gale